Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study.
Wajd AlkabbaniArsene ZongoJasjeet K Minhas-SandhuDean T EurichBaiju R ShahMhd Wasem AlsabbaghJohn-Michael GamblePublished in: BMJ open diabetes research & care (2021)
Our findings support a renoprotective effect of SGLT2-i without an increased risk of AKI, compared with clinically relevant active comparators.
Keyphrases